Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sphingomyelinase <strong>Inhibitor</strong>s<br />
Ceramide, a sphingosine-based lipid-signaling molecule,<br />
has gained serious attention as an important signaling<br />
molecule in cell cycle, cell differentiation, apoptosis, and<br />
immune response. Ceramide is generated either through<br />
de novo synthesis mediated by ceramide synthase or<br />
through hydrolysis of membrane sphingomyelin by<br />
an acid or neutral sphingomyelinase. Acid and neutral<br />
sphingomelinases differ in their ion dependence, pH<br />
optima, and cellular localization. Recent evidence<br />
suggests that the activation of a non-specific lipid<br />
scramblase during apoptosis induces the flipping of<br />
sphingomyelin from the cell surface to the cytoplasm<br />
side of the plasma membrane where it is cleaved by<br />
neutral sphingomyelinase to generate ceramide. The<br />
production of ceramide induces blebbing of the plasma<br />
membrane and aids in rapid engulfment by phagocytes.<br />
Neutral sphingomyelinase-released ceramide has also<br />
been shown to be essential for capping of L-selectin in<br />
lymphocytes.<br />
Sphingomyelinase <strong>Inhibitor</strong>s<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Lipid Signaling<br />
Some evidence exists indicating that acid<br />
sphingomyelinase deficient cells have defects in<br />
apoptotic signaling pathways. Sphingomyelin is<br />
usually rapidly broken down in the late endosomes and<br />
lysosomes. Hence, in acid sphingomyelinase deficiency,<br />
sphingomyelin may be kinetically trapped in lysosomes<br />
and disrupt endocytic trafficking of raft-associated<br />
cell surface signaling molecules. Defects in acid<br />
sphingomyelinase have also been linked to lysosomal<br />
storage disease known as Niemann-Pick disease, which<br />
results in progressive enlargement of liver and spleen.<br />
References:<br />
Cremesti, A.E., et al. 2002. FEBS Lett. 531, 47.<br />
Sillence, D.J. 200 . BMC Cell Biology 2, 24.<br />
Zhang, Y., et al. 200 . J. Biol. Chem. 276, 775.<br />
Tomiuk, S., et al. 998. Proc. Natl. Acad. Sci. USA 95, 3638.<br />
Product Cat. No. Comments Size Price<br />
Chlorpromazine,<br />
Hydrochloride<br />
215921 {2-Chloro-10-[3´-(dimethylamino)propyl]phenothiazine, HCl}<br />
An inhibitor of calmodulin-dependent phosphodiesterase I (IC 50 = 7 mM) that<br />
acts as an inhibitor of lysosomal sphingomyelinase.<br />
3,4-Dichloroisocoumarin 287815 A serine protease inhibitor that blocks daunorubicin-induced neutral<br />
sphingomyelinase activation.<br />
Fumonisin B , Fusarium<br />
moniliforme<br />
344850 (FB 1 )<br />
A cell-permeable mycotoxin that inhibits sphingolipid biosynthesis in rat kidney<br />
and in liver microsomes by inhibition of sphingosine N-acyltransferase (ceramide<br />
synthase; IC 50 = 00 nM). Preferentially inhibits sphingomyelin biosynthesis in<br />
neuronal cells. Exhibits carcinogenic properties.<br />
Gentamycin Sulfate 345814 A broad-spectrum antibiotic that reduces sphingomyelinase activity in<br />
fibroblasts.<br />
Manumycin A, Streptomyces<br />
parvulus<br />
444170 A potent and selective inhibitor of farnesyl transferase (IC 50 = 5 mM) that acts as<br />
an irreversible inhibitor of neutral sphingomyelinase.<br />
N-SMase <strong>Inhibitor</strong>, GW4869 567715 (GW554869A; GW69A; Sphingomyelinase, Neutral, <strong>Inhibitor</strong> GW4869)<br />
A cell-permeable, symmetrical dihydroimidazolo-amide that acts as a potent,<br />
specific, and non-competitive inhibitor of neutral sphingomyelinase (N-SMase)<br />
(IC 50 = mM, rat brain N-SMase).<br />
N a -Tosyl-Phe Chloromethyl<br />
Ketone<br />
Squalene-2,3-oxide Cyclase <strong>Inhibitor</strong><br />
616387 (TPCK)<br />
A serine protease inhibitor that blocks daunorubicin-induced neutral<br />
sphingomyelinase activator and sphingomyelin hydrolysis.<br />
More online... www.calbiochem.com/inhibitors/sphingomyelinase<br />
500 mg $57<br />
0 mg $ 30<br />
250 mg<br />
g<br />
mg $69<br />
g $58<br />
mg $77<br />
mg $ 46<br />
Product Cat. No. Comments Size Price<br />
AMO 6 8 1712 Anticholesterolemic agent that can be used as an inhibitor of squalene-2,3-oxide<br />
cyclase to study the action of squalene epoxidase in the microsomal cholesterol<br />
biosynthetic pathway.<br />
$39<br />
$ 0<br />
250 g $ 29<br />
Technical Support<br />
Phone 800 628 8470<br />
E-mail calbiochem@emdbiosciences.com<br />
95